Bruker Corporation (BRKR)
Debt-to-capital ratio
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long-term debt | US$ in thousands | 2,061,800 | 2,264,500 | 2,132,000 | 1,357,300 | 1,160,300 | 1,098,600 | 1,122,500 | 1,109,000 | 1,200,500 | 1,136,800 | 1,171,000 | 1,205,400 | 1,221,800 | 717,500 | 721,100 | 715,800 | 842,300 | 828,200 | 924,200 | 914,800 |
Total stockholders’ equity | US$ in thousands | 1,781,200 | 1,807,000 | 1,789,200 | 1,415,300 | 1,377,200 | 1,208,800 | 1,231,200 | 1,180,300 | 1,113,800 | 937,000 | 970,500 | 1,017,000 | 1,070,500 | 1,075,600 | 1,002,000 | 967,700 | 961,200 | 952,100 | 897,400 | 915,600 |
Debt-to-capital ratio | 0.54 | 0.56 | 0.54 | 0.49 | 0.46 | 0.48 | 0.48 | 0.48 | 0.52 | 0.55 | 0.55 | 0.54 | 0.53 | 0.40 | 0.42 | 0.43 | 0.47 | 0.47 | 0.51 | 0.50 |
December 31, 2024 calculation
Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $2,061,800K ÷ ($2,061,800K + $1,781,200K)
= 0.54
The debt-to-capital ratio of Bruker Corporation has fluctuated over the past few years, ranging from 0.40 to 0.56. This ratio indicates the proportion of the company's capital that is financed through debt.
From March 31, 2020, to December 31, 2022, the debt-to-capital ratio showed a gradual increase from 0.50 to 0.55 before slightly decreasing to 0.52 by the end of December 2022. This increasing trend may suggest that Bruker Corporation was relying more on debt to fund its operations and investments during this period.
However, from March 31, 2023, to December 31, 2024, the debt-to-capital ratio fluctuated between 0.46 and 0.56. This fluctuation may indicate changes in the company's capital structure or debt management strategies during this period.
Overall, investors and analysts should closely monitor Bruker Corporation's debt-to-capital ratio to assess the company's financial health and leverage levels, as higher ratios may indicate higher financial risk and potential challenges in debt repayment.
Peer comparison
Dec 31, 2024